Neuron will soon step into providing Managed Care for chronic condition for its client/members in 2014. This will begin with DHA for the ENAYA population and slowly continue into the private sectors. Studies conducted world-wide have proven that Disease Management Program (DMP) of chronic conditions has lowered IP costs by at least 20% over a reasonable period of time.
Selected members can be involved in this program which will improve member wellness and directly reflect on member satisfaction. This would also prove beneficial to the clients in terms of lower costs by controlling complications.
Neuron is currently doing an extensive ground study on DHA facilities and private clinics prior to designing the DMP program suitable for its clients/members.